CollPlant Biotechnologies Ltd.
CLGNAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Dec 2, 2024 | H.C. Wainwright | Swayampakula Ramakanth | $11.00(+153%) | $4.34 | StreetInsider |
| Aug 5, 2024 | EF Hutton | Jason Kolbert | $14.00(+201%) | $4.65 | StreetInsider |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| D. Boral Capital | downgrade | Buy →Hold | Feb 6, 2026 |
| D. Boral Capital | maintain | Buy | Nov 28, 2025 |
| D. Boral Capital | maintain | Buy | Oct 20, 2025 |
| D. Boral Capital | maintain | Buy | Sep 16, 2025 |
| HC Wainwright & Co. | maintain | Buy | Aug 21, 2025 |
| D. Boral Capital | maintain | Buy | Aug 20, 2025 |
| D. Boral Capital | maintain | Buy | May 30, 2025 |
| D. Boral Capital | maintain | Buy | May 28, 2025 |
| D. Boral Capital | maintain | Buy | Mar 27, 2025 |
| D. Boral Capital | maintain | Buy | Feb 12, 2025 |
| D. Boral Capital | maintain | Buy | Feb 4, 2025 |
| HC Wainwright & Co. | maintain | Buy | Nov 29, 2024 |
| D. Boral Capital | maintain | Buy | Nov 27, 2024 |
| HC Wainwright & Co. | maintain | Buy | Aug 21, 2024 |
| EF Hutton | maintain | Buy | Aug 20, 2024 |
| HC Wainwright & Co. | maintain | Buy | May 30, 2024 |
| HC Wainwright & Co. | maintain | Buy | Apr 5, 2024 |
| HC Wainwright & Co. | maintain | Buy | Nov 30, 2023 |
| HC Wainwright & Co. | maintain | Buy | Aug 25, 2023 |
| HC Wainwright & Co. | maintain | Buy | Mar 30, 2023 |
| Alliance Global Partners | maintain | Buy | Feb 17, 2023 |
| HC Wainwright & Co. | maintain | Buy | Feb 9, 2021 |
| HC Wainwright & Co. | maintain | Buy | Nov 25, 2020 |
| H.C. Wainwright | maintain | Buy | Nov 25, 2020 |
| HC Wainwright & Co. | maintain | Buy | May 28, 2020 |
Earnings History
Next report: Dec 2, 2026 · EPS est. $-0.53| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Sep 30, 2026 | $-1.89 | $-2.45 | $108.0K | $480.0K |
| May 29, 2026 | $-0.23 | $-0.24 | $73.0K | $460.0K |
| Mar 26, 2026 | $-0.67 | $-2.98 | $60.0K | $2.1M |
| Nov 26, 2025 | $-2.70 | $1.55 | $77.0K | $4.8M |
| Aug 20, 2025 | $-2.80 | $-1.00 | $179.0K | $2.5M |
| May 28, 2025 | $-0.13 | $-3.70 | $2.1M | $2.6M |
| Apr 3, 2025 | $-0.33 | $-4.20 | $165.0K | $100.0K |
| Nov 27, 2024 | $-3.80 | $-2.80 | $4.0K | $416.0K |
News
Government-backed R&D program to advance next-generation LPU hardware and expand the LPU Lab platform Builds on LightSolver's recent commercial and technical momentum, including the strategic partnership with Boeing, peer-reviewed research with HLRS and a growing IP portfolio
Rehovot, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its Board of Directors has approved a proposal to change the Company's name to OptiPhi Computing Ltd.
Rehovot, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd.
Transaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing Development REHOVOT, Israel, Oct. 9, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), an innovative technology company operating at the intersection of deep-tech photonic computing and biotechnology today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 989,301 of the Company's ordinary shares (or ordinary share equivalents in …
CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio REHOVOT, Israel, Oct. 6, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary, LightSolver, has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for an invention that significantly expands the capabilities of its all-optical, laser-based computing platform.
CareDx (NASDAQ: CDNA - Get Free Report) and CollPlant Biotechnologies (NASDAQ: CLGN - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings. Risk and Volatility CareDx has a beta of 2.38,
Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in Regenerative Medicine REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), today announced financial results for the second quarter of 2026 and provided a corporate update.
CollPlant Biotechnologies Ltd. Sponsored ADR (NASDAQ: CLGN - Get Free Report) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totaling 52,237 shares, a decline of 60.2% from the August 31st total of 131,118 shares. Based on an average daily trading volume,
Peer-reviewed study published by ACM: LightSolver's LPU architecture demonstrated significantly lower projected time-to-solution, compared to state-of-the-art algorithms running on a GPU REHOVOT, Israel, September 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced the publication of joint research conducted by its subsidiary LightSolver Ltd.
Nasdaq confirms the Company satisfies continued listing criteria under Listing Rule 5550(a)(2), officially closing the compliance matter Follows the recent completion of the LightSolver acquisition, marking CollPlant's strategic expansion into high-performance computing (HPC) and photonics REHOVOT, Israel, Sept. 22, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing Transcript
REHOVOT, Israel, Sept. 10, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd.
LightSolver Founder and CEO brings deep scientific and entrepreneurial expertise to CollPlant's Board as the Company advances the commercialization of its newly acquired photonic computing technology REHOVOT, Israel, Sept. 4, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd.
Technological Edge - LightSolver advances the development of the world's first Laser Processing Unit (LPU) – an energy-efficient, pure photonic computing platform Accelerated Growth Path - The transaction positions LightSolver to accelerate its path towards commercialization and expand engagements with strategic partners. REHOVOT, Israel, Sept.
REHOVOT, Israel, Sept. 1, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd.
LightSolver is pioneering pure photonic computing, bringing a new computing architecture to the public markets to address the speed, energy and heat limitations of semiconductor-based computing LightSolver has developed the world's first Laser Processing Unit™ (LPU™), combining the advantages of classical and quantum computing in a compact platform that operates without cryogenic or other extreme conditions and is designed for commercial deployment. Commercial validation is underway with global …